Table 2 Clinical characteristics of patients during hospitalization
Characteristic (n = 1546) | N/% |
|---|---|
Severity grades | |
Moderate | 1157/74.84 |
Severe | 389/25.16 |
Allergic/atopic status | 567/36.67 |
FEV1 after discharge | |
≥ 81 % predicted | 53/3.43 |
50–80 % predicted | 755/48.84 |
≤ 50 % predicted | 522/33.76 |
Not measured | 216/13.97 |
Hospital days | |
≤ 7d | 712/46.05 |
8–14d | 581/37.58 |
≥ 15d | 253/16.36 |
Complications and comorbidities | |
None | 291/18.82 |
Allergic rhinitis | 379/24.51 |
COPD | 452/29.24 |
Pneumonia | 525/33.96 |
Respiratory failure | 248/16.04 |
Circulation system disease | 744/48.12 |
pulmonary hypertension and cor pulmonale | 364/23.54 |
hypertension | 278/17.98 |
coronary heart disease | 325/21.02 |
other heart diseases | 87/5.63 |
Nervous system disease | 160/10.35 |
Digestive system disease | 233/15.07 |
GORD | 132/8.54 |
Gastritis | 129/8.34 |
Digestive ulcer | 106/6.86 |
Others | 125/8.09 |
Application of ICS + LABA/ICS + LAMA during hospitalization regularly | 1426/92.23 |
Obtaining asthma-associated education from doctor during hospitalization | 1474/95.34 |